Table 1.
Demographic details of subjects.
| Breast cancer (n = 259) | |
| Age in years [mean ± SD (range)] | 45.4 ± 10.5 (19–70) |
| aHistology type | |
| Number | |
| Invasive ductal carcinoma (IDC) | 182 |
| IDC with ductal carcinoma in situ (DCIS) | 8 |
| IDC + mucinous carcinoma | 6 |
| DCIS + cribriform type | 2 |
| Papillary carcinoma | 1 |
| Ductal adenocarcinoma | 2 |
| Lobular carcinoma | 3 |
| Medullary carcinoma | 1 |
| Neuroendocrine tumor | 1 |
| Malignant phyllodes | 1 |
| Pagets disease | 1 |
| Fibrous stroma | 1 |
| AJCC stage | |
| IIA | 52 |
| IIB | 49 |
| IIIA | 45 |
| III (B + C) | 113 |
| Hormone receptor status | |
| ER+ | 93 |
| ER− | 92 |
| PR+ | 82 |
| PR− | 100 |
| HER2+ | 56 |
| HER2− | 84 |
| HER2 2+ | 23 |
| Triple negative (TN) | 26 |
| Non-triple negative (nTN) | 155 |
| Triple positive (TP) | 13 |
| Benign lesions (n = 67) | |
| Age in years [mean ± SD (range)] | 30 ± 9.4 (13–61) |
| Histology type | |
| Number | |
| Fibroadenoma | 33 |
| Phyllodes | 8 |
| Benign ductal epithelial cells | 8 |
| Fibrocystic fibroadenoma | 8 |
| Cysts | 6 |
| Benign proliferative breast disease | 1 |
| Fibroepithelial lesion | 1 |
| Sclerosing adenosis | 1 |
| Mastitis | 1 |
| Healthy volunteers (n = 54) | |
| Age in years [mean ± SD (range)] | 30 ± 9.4 (13–61) |
aHistopathology available for 209 breast cancer patients only.